Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
MannKind Corporation - Common Stock
(NQ:
MNKD
)
3.770
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, May 29, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about MannKind Corporation - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
MannKind Corporation to Participate in Oppenheimer 33rd Annual Healthcare Conference
March 07, 2023
From
MannKind
Via
GlobeNewswire
Looking Into MannKind's Return On Capital Employed
↗
February 27, 2023
Via
Benzinga
MannKind To Rally Around 30%? Here Are 10 Other Analyst Forecasts For Monday
↗
February 27, 2023
Piper Sandler cut the price target for CS Disco, Inc. (NYSE: LAW) from $11 to $7.5. Piper Sandler analyst Arvind Ramnani downgraded the stock from Overweight to Neutral. CS Disco shares fell 1.2% to...
Via
Benzinga
Kratos Defense & Security, Zeta Global, Beacon Roofing Supply And Other Big Stocks Moving Higher On Friday
↗
February 24, 2023
U.S. stocks traded lower, with the Dow Jones dropping more than 400 points on Friday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
MannKind (MNKD) Q4 2022 Earnings Call Transcript
↗
February 24, 2023
MNKD earnings call for the period ending December 31, 2022.
Via
The Motley Fool
MannKind Earnings Preview
↗
February 22, 2023
Via
Benzinga
MannKind's Return On Capital Employed Overview
↗
December 05, 2022
Via
Benzinga
MannKind Corporation Reports 2022 Fourth Quarter and Full Year Financial Results
February 23, 2023
Conference Call to Begin Today at 5:00 p.m. (ET)
From
MannKind
Via
GlobeNewswire
MannKind to Give Oral Presentation on Meal Challenge Results From the Afrezza® With Basal Combination (ABC Study) at 16th Annual ATTD Conference
February 22, 2023
From
MannKind
Via
GlobeNewswire
MannKind Corporation to Hold 2022 Fourth Quarter and Full Year Financial Results Conference Call on February 23, 2023
February 16, 2023
From
MannKind
Via
GlobeNewswire
MannKind Corporation (MNKD) Q3 2022 Earnings Call Transcript
↗
November 08, 2022
MNKD earnings call for the period ending September 30, 2022.
Via
The Motley Fool
MannKind: Q2 Earnings Insights
↗
August 09, 2022
MannKind (NASDAQ:MNKD) reported its Q2 earnings results on Tuesday, August 9, 2022 at 04:00 PM. Here's what investors need to know about the announcement.
Via
Benzinga
Earnings Scheduled For February 23, 2023
↗
February 23, 2023
Companies Reporting Before The Bell • ChipMOS TECHNOLOGIES (NASDAQ:IMOS) is likely to report earnings for its fourth quarter.
Via
Benzinga
Mannkind Corporation to Participate in the SVB Securities Global Biopharma Conference
February 10, 2023
From
MannKind
Via
GlobeNewswire
MannKind Corporation to Participate in the Lytham Partners Investor Select Conference
January 24, 2023
From
MannKind
Via
GlobeNewswire
MannKind’s Inhaled Clofazimine Will Advance to an Adaptive Phase 2/3 Study For Potential Treatment of Rare Lung Disease
January 23, 2023
From
MannKind
Via
GlobeNewswire
3 Biotech Stocks Under $15 Worth a Second Look in 2023
↗
January 18, 2023
All three stocks have promising therapies that could drive revenue in the coming years.
Via
The Motley Fool
MannKind Corporation to Present at 2023 Annual J.P. Morgan Healthcare Conference
January 05, 2023
From
MannKind
Via
GlobeNewswire
MannKind to Present Two Posters at 22nd Annual Diabetes Technology Meeting
November 10, 2022
From
MannKind
Via
GlobeNewswire
MannKind To Rally 57%? Here Are 5 Other Price Target Changes For Wednesday
↗
November 09, 2022
Via
Benzinga
Tyson Foods To $61? Plus Needham Slashes PT On This Stock By 33%
↗
November 09, 2022
B of A Securities cut the price target on Tyson Foods, Inc. (NYSE: TSN) from $73 to $61. Tyson Foods shares fell 1.9% to $66.44 in pre-market trading.
Via
Benzinga
MannKind Corporation Reports 2022 Third Quarter Financial Results
November 08, 2022
Conference Call to Begin Today at 9:00 a.m. (ET)
From
MannKind
Via
GlobeNewswire
Earnings Preview: MannKind
↗
November 07, 2022
MannKind (NASDAQ:MNKD) is set to give its latest quarterly earnings report on Tuesday, 2022-11-08. Here's what investors need to know before the announcement. Analysts estimate that MannKind will...
Via
Benzinga
MannKind Corporation to Hold 2022 Third Quarter Financial Results Conference Call on November 8, 2022
November 01, 2022
From
MannKind
Via
GlobeNewswire
7 Penny Sleeper Stocks to Buy Before Wall Street Wakes Up
↗
September 29, 2022
While these market ideas are risky, they offer enough relevance to be intriguing.
Via
InvestorPlace
7 Penny Stocks That Actually Have a Buy Rating
↗
September 19, 2022
Penny stocks are always a risky proposition. However, investors can still find penny stocks with buy ratings right now.
Via
InvestorPlace
MannKind Shares Fall After Completing Initial Stage Lung Disease Study
↗
September 06, 2022
MannKind Corporation (NASDAQ: MNKD) has successfully completed a Phase 1 study of clofazimine inhalation suspension (MNKD 101), an inhalation treatment option for nontuberculous mycobacterial (NTM)...
Via
Benzinga
Earnings Outlook For MannKind
↗
August 08, 2022
MannKind (NASDAQ:MNKD) is set to give its latest quarterly earnings report on Tuesday, 2022-08-09. Here's what investors need to know before the announcement. Analysts estimate that MannKind will...
Via
Benzinga
Jim Cramer Recommends Selling This Stock: 'No One Ever Likes Me To Say Anything Bad' About This Company
↗
August 04, 2022
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Canoo Inc. (NASDAQ: GOEV) is losing money. "We’re done with those stocks that just lose money," he added.
Via
Benzinga
The Daily Biotech Pulse: Pfizer-BioNTech's COVID-19 Booster For Kids 5-11 Coming Soon, Ultragenyx In-Licenses Gene Therapy For Genetic Disorder, Ampio's AP-013 Trial Under Independent Investigation
↗
May 17, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
